Narjust Duma, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Astrazeneca
    Topic: 
    Advisory board
    Date added: 
    09/28/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pfizer
    Topic: 
    Advisory board
    Date added: 
    09/28/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    BMS
    Topic: 
    Advisory board
    Date added: 
    09/28/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    BI oncology
    Topic: 
    Advisory board
    Date added: 
    09/28/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen
    Topic: 
    Advisory board
    Date added: 
    09/28/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Inivata/Neogenomics
    Topic: 
    Tumor board moderator
    Date added: 
    09/28/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Nexus Oncology
    Topic: 
    CME content
    Date added: 
    09/28/2021
Return to 2022 Summit on Cancer Health Disparities